Galectin‑9 ameliorates fulminant liver injury.

about

Galectin‑9 ameliorates fulminant liver injury.

Item

http://www.wikidata.org/entity/Q40189490

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Galectin‑9 ameliorates fulminant liver injury.

@en

type

Item

label

Galectin‑9 ameliorates fulminant liver injury.

@en

prefLabel

Galectin‑9 ameliorates fulminant liver injury.

@en

P1476

Galectin‑9 ameliorates fulminant liver injury.

@en

P2093

Asahiro Morishita

http://www.w3.org/2001/XMLSchema#string

Hirohito Yoneyama

http://www.w3.org/2001/XMLSchema#string

Hisakazu Iwama

http://www.w3.org/2001/XMLSchema#string

Joji Tani

http://www.w3.org/2001/XMLSchema#string

Koji Fujita

http://www.w3.org/2001/XMLSchema#string

Kyoko Oura

http://www.w3.org/2001/XMLSchema#string

Mitsuomi Hirashima

http://www.w3.org/2001/XMLSchema#string

Shima Mimura

http://www.w3.org/2001/XMLSchema#string

Shintaro Fujihara

http://www.w3.org/2001/XMLSchema#string

Takako Nomura

http://www.w3.org/2001/XMLSchema#string

P2860

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

Emerging role of microRNAs in liver diseases

Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance

The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

miR-181a is an intrinsic modulator of T cell sensitivity and selection

Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance

Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery disease

Ribo-gnome: the big world of small RNAs

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

P304

36-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2017.6606

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28534962

http://www.w3.org/2001/XMLSchema#string

P932

5482106

http://www.w3.org/2001/XMLSchema#string